Functional Task Kinematic in Musculoskeletal Pathology.

Sponsor
University of Malaga (Other)
Overall Status
Completed
CT.gov ID
NCT03293095
Collaborator
Vrije Universiteit Brussel (Other)
50
1
30.1
1.7

Study Details

Study Description

Brief Summary

The aim of this project is to create references values to patients with musculoskeletal pathology using functional tasks and measuring with a smartphone and video imaging (3D motion capture cameras).

Condition or Disease Intervention/Treatment Phase
  • Procedure: Standard Care

Detailed Description

Musculoskeletal pathologies can affect bones, muscles, joints and other structures related to this system. These disorders are extremely common and can have an origin from autoimmune, inflammatory, traumatic, etc. The risk of developing this pathologies increases with age.

The diagnosis could delayed by lack of information, expensive assessment or difficult execution.

Currently, you can use a Smartphone to get the same information as sensors. In addition to Smartphone, 3D motion capture systems with a camera have been frequently used to analyse kinematics and are being integrated as a rehabilitation tool in patients. The use of Smartphones and 3D motion capture cameras would help to find fast and cheap assessment methods for professionals.

Study Design

Study Type:
Observational
Actual Enrollment :
50 participants
Observational Model:
Cohort
Time Perspective:
Cross-Sectional
Official Title:
Functional Task Kinematic in Patient With Musculoskeletal Pathology.
Actual Study Start Date :
Mar 1, 2018
Actual Primary Completion Date :
Feb 1, 2020
Actual Study Completion Date :
Sep 1, 2020

Arms and Interventions

Arm Intervention/Treatment
Acute musculoskeletal pathology patients

Musculoskeletal pathology patients that they will perform functional tasks measuring with motion sensors and motion capture.

Procedure: Standard Care
The guidelines for the management according to the musculoskeletal disorder in primary care will be the treatment guidelines for the Standard Care.

Match control

Healthy people of the same age as the acute musculoskeletal pathology subjects. They will perform functional tasks measuring with motion sensors and motion capture.

Procedure: Standard Care
The guidelines for the management according to the musculoskeletal disorder in primary care will be the treatment guidelines for the Standard Care.

Outcome Measures

Primary Outcome Measures

  1. Kinematic analysis by motion sensor [1 hour]

    A smartphone will pick up positioning, motion and acceleration information from the subject

  2. Kinematic analysis by 3D motion capture [1 hour]

    The camera will perform a motion capture of the functional task. This system will calculate the displacement and the time of the functional task

  3. Responsiveness [1 hour]

    The Responsiveness Box of COSMIN checklist will be used to determinate the response to change of the Smartphone and the 3D cameras. All possible items will be followed.

Secondary Outcome Measures

  1. Quality of life questionnaire: EuroQoL 5D [1 hour]

    standardized instrument for use as a measure of health outcome

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Persons with diagnosis of musculoskeletal pathology.

  • Age between 20-65 años.

  • Subjects able to get up from the chair at least 5 times.

  • Be able to complete questionnaires and perform functional tasks.

Exclusion Criteria:
  • Subjects who are participating in a study with an experimental treatment.

  • Severe cardiovascular disease.

  • Being pregnant, in case of women.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Malaga Málaga Spain 29009

Sponsors and Collaborators

  • University of Malaga
  • Vrije Universiteit Brussel

Investigators

  • Principal Investigator: Antonio I Cuesta-Vargas, PhD, University of Malaga

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Dr. Antonio I Cuesta-Vargas, PhD, University of Malaga
ClinicalTrials.gov Identifier:
NCT03293095
Other Study ID Numbers:
  • iBAFI01
First Posted:
Sep 26, 2017
Last Update Posted:
Sep 29, 2020
Last Verified:
Jul 1, 2019
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Dr. Antonio I Cuesta-Vargas, PhD, University of Malaga
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 29, 2020